4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-044561
President and CEO sold 2,314 shares at $4.48 ($10,367)
From the SEC's structured data for this filing
Trades in this filing
Paulson Richard A. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-04 | Sale : show line 1 in the form | −2,314 | $4.48 | $10,367 | 626,477 | D |
| Open-market sales · 2,314 sh · avg $4.48 · $10,367 | ||||||
Loading xslF345X03/doc4.xml…